Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by ompong12on Oct 26, 2020 12:25pm
254 Views
Post# 31781755

pp for 3000 test a day

pp for 3000 test a dayi can't barely understand whats happening since we do this pp last july and was preceded by rs. that time the target is 1000 test a day....THE BIG QUESTION IS DO WE HIT ALREADY THAT 1000 TARGET? AND IF WE HIT IT WHY THE MANAGEMENT DIDN'T GIVE AN UPDATE? It make no sense to me to run again a PP for 3000 test  a day ......considering we didn't know if that 1000 test a day is has been hit already. Or is it safe to assume it was achieved already...but we need black and white for us to see. management need transparency to all not only to clarus and echelon. clarus and echelon is not only the investor of this company....

or do the Investor need to get in first to get a cheap price before they reveal the info that will propel this company to $5 sp. i hope so that is their strategy. patience patience patience ......we need more of it.
 
<< Previous
Bullboard Posts
Next >>